ABEL TRIMINO ESPINOSA: Open Payments
NPI 1205347705 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 13 payments from 6 companies in 2025. Trend: 2023 $226 · 2024 $132 · 2025 $255
Food & beverage: $255
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $136 |
| Phadia US Inc. | 2 | $40 |
| Lilly USA, LLC | 1 | $23 |
| ABBVIE INC. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
Products named: FARXIGA, BREZTRI, JARDIANCE, ImmunoCAP, QULIPTA, Ozempic, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
